Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:232708rdf:typepubmed:Citationlld:pubmed
pubmed-article:232708lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:232708lifeskim:mentionsumls-concept:C0039663lld:lifeskim
pubmed-article:232708lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:232708lifeskim:mentionsumls-concept:C0042036lld:lifeskim
pubmed-article:232708lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:232708lifeskim:mentionsumls-concept:C0034580lld:lifeskim
pubmed-article:232708lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:232708lifeskim:mentionsumls-concept:C0008565lld:lifeskim
pubmed-article:232708lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:232708pubmed:dateCreated1980-8-25lld:pubmed
pubmed-article:232708pubmed:abstractTextA high-performance liquid chromatography-radioimmunoassay method for the measurement of cannabinoids in urine is described. The method involves chromatographing a hydrolysed urine sample with high-performance liquid chromatography and quantifying the eluting cross-reacting cannabinoids with radioimmunoassay. It has been applied to the analysis of cannabinoids in human urine obtained from subjects who had smoked delta 9-tetrahydrocannabinol and the identities of some of the cross-reacting cannabinoids have been established by gas chromatography-mass spectrometry. The method is suitable for use as a routine procedure for cannabinoid analysis in urine.lld:pubmed
pubmed-article:232708pubmed:languageenglld:pubmed
pubmed-article:232708pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:232708pubmed:citationSubsetIMlld:pubmed
pubmed-article:232708pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:232708pubmed:statusMEDLINElld:pubmed
pubmed-article:232708pubmed:monthDeclld:pubmed
pubmed-article:232708pubmed:issn0021-9673lld:pubmed
pubmed-article:232708pubmed:authorpubmed-author:MoffatA CAClld:pubmed
pubmed-article:232708pubmed:authorpubmed-author:KingL JLJlld:pubmed
pubmed-article:232708pubmed:authorpubmed-author:WilliamsP LPLlld:pubmed
pubmed-article:232708pubmed:issnTypePrintlld:pubmed
pubmed-article:232708pubmed:day30lld:pubmed
pubmed-article:232708pubmed:volume186lld:pubmed
pubmed-article:232708pubmed:ownerNLMlld:pubmed
pubmed-article:232708pubmed:authorsCompleteYlld:pubmed
pubmed-article:232708pubmed:pagination595-603lld:pubmed
pubmed-article:232708pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:232708pubmed:meshHeadingpubmed-meshheading:232708-H...lld:pubmed
pubmed-article:232708pubmed:meshHeadingpubmed-meshheading:232708-R...lld:pubmed
pubmed-article:232708pubmed:meshHeadingpubmed-meshheading:232708-C...lld:pubmed
pubmed-article:232708pubmed:meshHeadingpubmed-meshheading:232708-T...lld:pubmed
pubmed-article:232708pubmed:meshHeadingpubmed-meshheading:232708-C...lld:pubmed
pubmed-article:232708pubmed:year1979lld:pubmed
pubmed-article:232708pubmed:articleTitleCombined high-performance liquid chromatography and radioimmunoassay method for the analysis of delta 9-tetrahydrocannabinol metabolites in human urine.lld:pubmed
pubmed-article:232708pubmed:publicationTypeJournal Articlelld:pubmed